Pfizer’s Lorbrena receives FDA approval for advanced lung cancer treatment

Pfizer Inc., a leading US pharmaceutical company, has secured approval from the US Food and Drug Administration (FDA) for Lorbrena (lorlatinib), a groundbreaking treatment for ... Read More